AU5331200A - Methods and compositions for treating raynaud's phenomenon and scleroderma - Google Patents

Methods and compositions for treating raynaud's phenomenon and scleroderma

Info

Publication number
AU5331200A
AU5331200A AU53312/00A AU5331200A AU5331200A AU 5331200 A AU5331200 A AU 5331200A AU 53312/00 A AU53312/00 A AU 53312/00A AU 5331200 A AU5331200 A AU 5331200A AU 5331200 A AU5331200 A AU 5331200A
Authority
AU
Australia
Prior art keywords
scleroderma
phenomenon
compositions
methods
treating raynaud
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53312/00A
Inventor
Maqsood Chotani
Nicholas Flavahan
Sheila Flavahan
Srabani Mitra
Baogen Su
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University Research Foundation
Original Assignee
Ohio State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University Research Foundation filed Critical Ohio State University Research Foundation
Publication of AU5331200A publication Critical patent/AU5331200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
AU53312/00A 1999-06-11 2000-06-09 Methods and compositions for treating raynaud's phenomenon and scleroderma Abandoned AU5331200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13893999P 1999-06-11 1999-06-11
US60138939 1999-06-11
PCT/US2000/015906 WO2000076502A1 (en) 1999-06-11 2000-06-09 Methods and compositions for treating raynaud's phenomenon and scleroderma

Publications (1)

Publication Number Publication Date
AU5331200A true AU5331200A (en) 2001-01-02

Family

ID=22484344

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53312/00A Abandoned AU5331200A (en) 1999-06-11 2000-06-09 Methods and compositions for treating raynaud's phenomenon and scleroderma

Country Status (2)

Country Link
AU (1) AU5331200A (en)
WO (1) WO2000076502A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266776A1 (en) 2003-06-25 2004-12-30 Gil Daniel W. Methods of preventing and reducing the severity of stress-associated conditions
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
US8394800B2 (en) 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
AU2011231544B2 (en) 2010-03-26 2015-01-15 Galderma Research & Development Improved methods and compositions for safe and effective treatment of telangiectasia
MX2012010824A (en) 2010-03-26 2012-10-10 Galderma Res & Dev Improved methods and compositions for safe and effective treatment of erythema.
WO2012052479A2 (en) 2010-10-21 2012-04-26 Galderma S.A. Brimonidine gel compositions and methods of use
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965595A (en) * 1993-07-01 1999-10-12 The Procter & Gamble Company 2-Imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives

Also Published As

Publication number Publication date
WO2000076502A1 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
AU3067399A (en) Oxygen-scavenging compositions and articles
AU9214398A (en) Compositions and methods for treating water
EP1066018B8 (en) Hair treatment compositions
AU1296099A (en) Methods and compositions for treating dermatoses
AUPQ419099A0 (en) Novel compositions and methods
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2790199A (en) Biochemical compositions used in human treatment
AU2113295A (en) Novel compositions and methods for water treatment
PL327659A1 (en) Disinfecting compositions and surface disinfecting methods
AUPQ127399A0 (en) Compositions and methods for treating or preventing osteoporosis
AU4813197A (en) Compositions and methods for treating viral infections
AU2327599A (en) Compositions and methods for treating autoimmune diseases
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU2349399A (en) R-lansoprazole compositions and methods
HUP0103562A3 (en) Novel compositions and use
AU2660900A (en) 4-haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines and their use as repellents
AU2972597A (en) Compositions and uses thereof
AU1403501A (en) Novel composition and use
AU2111399A (en) Wear reducing compositions and methods for their use
AU5331200A (en) Methods and compositions for treating raynaud's phenomenon and scleroderma
EP1073333A4 (en) S-rabeprazole compositions and methods
EP1139981A4 (en) Compositions and methods of using the same
AU1152601A (en) Compositions and their use
AU4859399A (en) Compositions and methods for treating papillomavirus-infected cells
AU4895297A (en) Methods and compositions for enhancing the expression of genes in plants

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase